Proteomic research: Potential opportunities for clinical and physiological investigators

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 6 49-6, 2004, Pages

  Nair, K Sreekumaran ^a   Jaleel, Abdul ^a   Asmann, Yan W ^a   Short, Kevin R ^a   Raghavakaimal, Sreekumar ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Mass spectrometry; Metabolic labeling; Protein modification; Protein quantification; Protein synthesis

Indexed keywords

CARBOHYDRATE; LIPID; PHOSPHATE; PROTEIN; SULFATE;

BIOINFORMATICS; CLINICAL RESEARCH; ISOTOPE LABELING; MASS SPECTROMETRY; PHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; TISSUE SPECIFICITY; TUMOR DIAGNOSIS;

ENDOCRINOLOGY; HUMANS; PHYSIOLOGY; PROTEOMICS;

EID: 2442710587     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00370.2003     Document Type: Review

References (96)

1. Aebersold R and Mann M. Mass spectrometry-based proteomics. Nature 422: 198-207, 2003.
2. Al-Majid S and McCarthy DO. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2: 186-197, 2001.
3. Alms GR, Sanz P, Carlson M, and Haystead TA. Reg 1p targets protein phosphatase 1 to dephosphorylate hexokinase II in Saccharomyces cervisiae. EMBO J 18: 4157-4168, 1999.
4. Archakov AI, Govorun VM, Dubanov AV, Ivanov YD, Veselovsky AV, Lewi P, and Janssen P. Protein-protein interactions as a target for drugs in proteomics. Proteomics 3: 380-391, 2003.
5. Balagopal P, Ljungqvist O, and Nair KS. Skeletal muscle myosin heavy-chain synthesis rate in healthy humans. Am J Physiol Endocrinol Metab 272: E45-E50, 1997.
6. Balagopal P, Schimke JC, Ades PA, Adey D, and Nair KS. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 280: E203-E208, 2001.
7. Banting FG and Best BA. Pancreatic extracts. 1922. J Lab Clin Med 115: 254-272, 1990.
8. Barrett EJ, Revkin JH, Young LH, Zaret BL, Jacob R, and Gelfand RA. An isotopic method for measurement of muscle protein synthesis and degradation in vivo. Biochem J 245: 223-228, 1987.
9. Bergen HRI, Ajtai K, Burghardt TP, Nepomuceno AI, and Muddiman DC. Mass spectral determination of skeletal/cardiac actin isoforms ratios in cardiac muscle. Rapid Commun Mass Spec 17: 1467-1471, 2003.
10. Biolo G, Gastaldelli A, Zhang XJ, and Wolfe RR. Protein synthesis and breakdown in skin and muscle: a leg model of amino acid kinetics. Am J Physiol Endocrinol Metab 267: E467-E474, 1994.
11. Boguski MS. Bioinformatics. Curr Opin Genet Dev 4: 383-388, 1994.
12. Boguski MS. The turning point in genome research. Trends Biochem Sci 20: 295-296, 1995.
13. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
14. Caprioli RM, Farmer TB, and Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 69: 4751-4760, 1997.
15. Chaurand P, Schwartz SA, and Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 6: 676-681, 2002.
16. Conover CA, Kiefer MC, and Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. J Clin Invest 91: 1129-1137, 1993.
17. Corbett JM, Why HJ, Wheeler CH, Richardson PJ, Archard LC, Yacoub MH, and Dunn MJ. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 19: 2031-2042, 1998.
18. De Feo P, Gan Gaisano M, and Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88: 833-840, 1991.
19. Dennis JW, Granovsky M, and Warren CE. Protein glycosylation in development and disease. BioEssays 21: 412-421, 1999.
20. DeWildt RM, Mundy CR, Gorick BD, and Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 18: 989-994, 2000.
21. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, Hunt DF, and White FM. Phosphoproteome analysis by mass spectometry and its application to Saccharaomyces cerevisiae. Nat Biotechnol 20: 301-305, 2002.
22. Fields S and Song O. A novel genetic system to detect protein-protein interactions. Nature 340: 245-246, 1989.
23. Freiberg C. Drug Discov Today 6: S72-S80, 2001.
24. Fromont-Racine M, Mayes AE, Brunet-Simon A, Rain JC, Colley A, Dix I, Decourty L, Joly N, Ricard F, Beggs JD, and Legrain P. Genome-wide protein interaction screens reveal functional networks involving Sm-like proteins. Yeast 17: 95-110, 2000.
25. Fu A, Morris JC, Ford GC, and Nair KS. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis. Anal Biochem 247: 228-236, 1996.
26. Fu A and Nair KS. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol Endocrinol Metab 275: E1023-E1030, 1998.
27. Galperin MY and Coonin EG. Searching for drug targets in microbial genomes. Curr Opin Biotech 10: 571-578, 1999.
28. Geyer H and Geyer R. Strategies for glycoconjugate analysis. Acta Anat 161: 18-35, 1998.
29. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5: 87-90, 2003.
30. Godovac-Zimmerman J and Brown LR. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom Rev 20: 1-57, 2001.
31. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899, 2003.
32. Goldberg AL and St. John AC. Intracellular protein degradation in mammalian and bacterial cells: Part 2. In: Annual Review of Biochemistry, edited by Snell EE, Boyer PD, Meister A, and Richardson CC. Palo Alto, CA: Annual Reviews, 1976, p. 747-803.
33. Graves PR and Haystead TA. A functional proteomics approach to signal transduction. Recent Prog Horm Res 58: 1-24, 2003.
34. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999.
35. Halvatsiotis P, Short KR, Bigelow ML, and Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 51: 2395-2404, 2002.
36. Hanash S. Disease proteomics. Nature 422: 226-232, 2003.
37. Hancock WS, Wu SL, and Shieh P. The challenges of developing a sound proteomics strategy. Proteomics 2: 352-359, 2002.
38. Kahn CR. Causes of insulin resistance. Nature 373: 384-385, 1995.
39. Kaufmann H, Bailey JE, and Fussenegger M. Use of antibodies for detection of phosphorylated proteins separated by two-dimensional gel electrophoresis. Proteomics 1: 194-199, 2001.
40. Kimball SR and Jefferson LS. Cellular mechanisms involved in the action of insulin on protein synthesis. Diabetes Metab Rev 4: 773-787, 1988.
41. Knecht M, Regitz-Zagrosek V, Pleissner KP, Jungblut P, Steffen C, Hildebrandt A, and Fleck E. Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J 15: 37-44, 1994.
42. Koketsu M and Linhardt RJ. Electrophoresis for the analysis of acidic oligosaccharides. Anal Biochem 283: 136-145, 2000.
43. Latif N, Rose ML, Yacoub MH, and Dunn MJ. Association of pretransplantation antiheart antibodies with clinical course after heart transplantation. J Heart Lung Transplant 14: 119-126, 1995.
44. Li XE, Pleissner KP, Scheler C, Rigitz-Zagrosek V, Sainikow J, and Jungblut PR. A two-dimensional electrophoresis database of rat heart proteins. Electrophoresis 20: 891-897, 1999.
45. Link AJ, Eng J, Schlietz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, and Yates JRI. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17: 676-682, 1999.
46. Luhn S, Berth M, Hecker M, and Bernhardt J. Using standard positions and image fusion to create proteome maps from collections of two-dimensional gel electrophoresis images. Proteomics 3: 1117-1127, 2003.
47. Maglott DR, Hatz KS, Sicotte H, and Pruitt KD. NCBI's LocusLink and RefSeq, Nacleic Acids Res 28: 126-128, 2000.
48. Molloy MP. Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal Biochem 280: 1-10, 2000.
49. Monribot-Espagne C and Boucherie H. Differential gel exposure, a new methodology for the two-dimensional comparison of protein samples. Proteomics 2: 229-240, 2002.
50. Morita H, Yano Y, Niswender KD, May JM, Whitesell RR, Wu L, Printz RL, Granner DK, Magnuson MA, and Powers AC. Coexpression of glucose transporters and glucokinase in Xenopus oocytes indicates that both glucose tranport and phosphorylation determine glucose utilization. J Clin Invest 94: 1373-1382, 1994.
51. Muller EC, Thiede B, Zimny-Arndt U, Scheler C, Prehm J, Muller-Werdan U, Wittman-Liebold B, Otto A, and Jungblut P. High-performance human myocardial two-dimensional electrophoresis database: edition 1996. Electrophoresis 17: 1700-1712, 1996.
52. Nair KS. Assessment of protein metabolism in diabetes. In: Clinical Research in Diabetes and Obesity, Part I: Methods, Assessment, and Metabolic Regulation, edited by Draznin B and Rizza RA. Totowa, NJ: Humana, 1995, p. 137-170.
53. Nair KS. Muscle protein turnover: methodological issues and the effect of aging. J Gerontol Biol Med Sci 50A: 107-112, 1995.
54. Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, and Wahren J. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 95: 2926-2937, 1995.
55. Nair KS, Halliday D, and Griggs RC. Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol Endocrinol Metab 254: E208-E213, 1988.
56. Nair KS, Welle SL, Halliday D, and Campbell RG. Effect of betahydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest 82: 198-205, 1988.
57. National Cancer Institute (NCI). Proteomics in Clinical Trials. www.newscenter.cancer.gov.2002.
58. Oda Y, Nagasu T, and Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 19: 379-382, 2001.
59. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021, 1975.
60. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, and Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386, 2002.
61. Pandey A and Mann M. Proteomics to study genes and genomes. Nature 405: 837-846, 2000.
62. Pankuweit S, Portig I, Lottspeich F, and Maisch B. Autoantibodies in sera of patients with myocarditis: characterizaton of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29: 77-84, 1997.
63. Patton WF. A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis 21: 1123-1144, 2000.
64. Patton WF. Detection technologies in proteome analysis. J Chromatogr 771: 3-31, 2002.
65. Patton WF, Schulenberg B, and Steinberg TH. Two-dimensional gel electrophoresis; better than a poke in the ICAT? Curr Opin Biotechnol 13: 321-328, 2002.
66. Petricoin EF III, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, and Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577, 2002.
67. Pleissner KP, Sander S, Oswald H, Regitz-Zagrosek V, and Fleck E. The construction of world wide web accessible myocardial two-dimensional gel electrophoresis protein database "HEART-2DPAGE": a practical approach. Electrophoresis 17: 1386-1392, 1996.
68. Pohlner K, Portig I, Pankuweit S, Lottspeich F, and Maisch B. Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 80: 1040-1045, 1997.
69. Pratt JM, Petty J, Riba-Garcia I, Robertson DH, Gaskell SJ, Oliver SG, and Beynon RJ. Dynamics of protein turnover, a missing dimension in proteomics. Mol Cell Proteomics 1: 579-591, 2002.
70. Pratt JM, Robertson DHL, Gaskell SJ, Riba-Garcia I, Hubbard SJ, Sidhu K, Oliver SG, Butler P, Hayes A, Petty J, and Beynon RJ. Stable isotope labelling in vivo as an aid to protein identification in peptide mass fingerprinting. Proteomics 2: 157-163, 2002.
71. Rain JC, Selig L, DeReuse H, Battaglia V, Reverdy C, Simon S, Lenzen G, Petel F, Wojcik J, Schachter V, Chemama Y, Labigne A, and Legrain P. The protein-protein interaction map of Helicobacter pylori. Nature 409: 211-215, 2001.
72. Randic M. On graphical and numerical characterization of proteomics maps. J Chem Inf Comput Sci 41: 1330-1338, 2001.
73. Rizza RA, Jensen MD, and Nair KS. Type 1 diabetes mellitus (insulin-dependent diabetes mellitus). In: Handbook of Physiology. The Endocrine System. The Endocrine Pancreas and Regulation of Metabolism. Bethesda, MD: Am. Physiol. Soc., 2001, sect. 7, vol. II, chapt. 36, p. 1093-1114.
74. Rooyackers OE, Adey DB, Ades PA, and Nair KS. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA 93: 15364-15369, 1996.
75. Rooyackers OE, Balagopal P, and Nair KS. Measurement of synthesis rates of specific muscle proteins using needle biopsy samples. Muscle Nerve Suppl 5: S93-S96, 1997.
76. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, and van Hinsbergh VW. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 48: 2446-2453, 1999.
77. Singh R, Barden A, Mori T, and Beilin L. Advanced glycation end-productions: a review. Diabetologia 44: 129-146, 2001.
78. Sreekumar R, Halvatsiotis P, Schimke JC, and Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920, 2002.
79. Sreekumar R, Unnikrishnan J, Fu A, Nygren J, Short KR, Schimke JC, Barazzoni R, and Nair KS. Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am J Physiol Endocrinol Metab 282: E1055-E1061, 2002.
80. Steinberg TH, Pretty on Top K, Berggren KN, Kemper C, Jones L, Diwu Z, Haugland RP, and Patton WF. Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics 1: 841-855, 2001.
81. Stoeckli M, Chaurand P, Hallahan DE, and Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7: 493-496, 2001.
82. Stump CS, Short KR, Bigelow ML, Schimke JC, and Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100: 7996-8001, 2003.
83. The International Human Genome Mapping Consortium. A physical map of the human genome. Nature 409: 934-941, 2001.
84. Tyers M and Mann M. From genomics to proteomics. Nature 422: 193-197, 2003.
85. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfieisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, and Rothberg JM. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403: 623-627, 2000.
86. Unlu M. Difference gel electrophoresis. Biochem Soc Trans 27: 547-549, 1999.
87. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, and Sutton GG. The sequence of the human genome. Science 291: 1304-1351, 2001.
88. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, Ido Y, Szczepanik A, Wade J, Mootha V, Cortright RN, Muoio DM, and Lowell BB. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 275: 16258-16266, 2000.
89. Walhout AJ, Sordella R, Lu X, Hartley JL, Temple GF, Brasch MA, Thierry-Mieg N, and Vidal M. Protein interaction mapping in C. elegans using proteins involved in vulval development. Science 287: 116-122, 2000.
90. Washburn MP, Wolters D, and Yates JRI. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19: 242-247, 2001.
91. Waterlow JC. Protein turnover in the whole body. Nature 253: 157, 1975.
92. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, and Rose ML. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant 14: S188-S197, 1995.
93. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphery-Smith I, Williams KL, and Hochstrasser DF. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology 14: 61-65, 1996.
94. Wulfkuhle JD, McLean KC, Paweletz CP, Sgroi DC, Trock BJ, Steeg PS, and Petricoin EF III. New approaches to proteomic analysis of breast cancer. Proteomics 1: 1205-1215, 2001.
95. Zhou H, Watts JD, and Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol 19: 375-378, 2001.
96. Zhu H and Snyder M. Protein chip technology. Curr Opin Chem Biol 7: 55-63, 2003.